Phibro Animal Health Corporation
PAHC
$39.45
$0.380.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.51% | 555.57% | -54.34% | 827.53% | -91.05% |
| Total Depreciation and Amortization | -12.89% | 9.00% | 28.54% | 15.96% | -15.56% |
| Total Amortization of Deferred Charges | 248.43% | 13.49% | 37.33% | -78.36% | 552.31% |
| Total Other Non-Cash Items | 708.36% | -88.05% | 196.92% | -112.09% | -170.20% |
| Change in Net Operating Assets | -269.13% | 147.63% | -1,003.68% | -90.63% | 303.48% |
| Cash from Operations | -50.71% | 1,302.93% | -75.63% | -55.60% | 149.20% |
| Capital Expenditure | -69.66% | 0.97% | 18.38% | 26.69% | -34.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 607.98% | 99.64% | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 108.03% | -124.76% | 473.79% | 67.96% | -63.38% |
| Cash from Investing | 61.46% | 92.99% | -8,789.86% | 67.84% | -906.28% |
| Total Debt Issued | -25.27% | -83.16% | -15.17% | 337.52% | 109.02% |
| Total Debt Repaid | 35.91% | 45.89% | 65.83% | -360.98% | -136.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.02% | -0.10% | 0.00% | 0.02% | -0.02% |
| Other Financing Activities | 500.39% | 33.42% | 84.22% | -563.41% | 224.66% |
| Cash from Financing | 75.90% | -111.66% | 1,046.40% | -1,733.86% | -63.19% |
| Foreign Exchange rate Adjustments | 102.17% | 116.28% | -605.62% | 201.67% | -423.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.36% | -144.10% | 181.15% | -192.09% | 18.16% |